Previous close | 87.66 |
Open | 87.49 |
Bid | 50.00 x 800 |
Ask | 91.29 x 1000 |
Day's range | 87.75 - 91.58 |
52-week range | 70.74 - 95.26 |
Volume | |
Avg. volume | 491,438 |
Market cap | 4.621B |
Beta (5Y monthly) | 0.36 |
PE ratio (TTM) | 36.99 |
EPS (TTM) | 2.46 |
Earnings date | 09 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 105.57 |
Haemonetics' (NYSE:HAE) stock is up by a considerable 12% over the past month. Given the company's impressive...
Recovery within the Hospital business and the favorable prospects of the Plasma franchise raise investors' optimism for Haemonetics (HAE).
Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish fourth quarter and fiscal year 2024 financial results at 6:00 am ET on Thursday, May 9, 2024. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am ET on May 9, 2024.